NK phenotypic markers and IL2 response in NK cells from elderly people

Experimental Gerontology

Volumn 34, Issue 2, 1999, Pages 253-265

  Borrego, F ^a   Alonso, M C ^a   Galiani, M D ^a   Carracedo, J ^a   Ramirez, R ^a   Ostos, B ^a   Pena J ^a   Solana, R ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Aging; CD56; CD57; CD69; Immunosenescence; NK cells; Proliferation

Indexed keywords

CALCIUM ION; INTERLEUKIN 2;

ADULT; AGED; AGING; ARTICLE; CALCIUM MOBILIZATION; CELL STRAIN K 562; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD3; ANTIGENS, CD56; BIOLOGICAL MARKERS; CALCIUM; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033026570     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00076-X     Document Type: Article

References (55)

1. Abo T., Watanabe H., Sato K., Iiai T., Moroda T., Takeda K., Seki S. Extrathymic T cells stand at an intermediate phylogenetic position between natural killer cells and thymus-derived T cells. Nat Immun. 14:1995;173-187.
2. Ales-Martinez J.E., Alvarez-Mon M., Merino F., Bonilla F., Martinez C., Durantez A., De La Hera A. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3-CD2+ natural killer cells. Eur J Immunol. 18:1988;1827-1830.
3. Arai K., Yamamura S., Seki S., Hanyu T., Takahashi H.E., Abo T. Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients Implication for an anti-inflammatory role . Clin Exp Immunol. 111:1998;345-352.
4. Arase N., Arase H., Park S.Y., Ohno H., Ra C., Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+T cells. J Exp Med. 186:1997;1957-1963.
5. Baume D.M., Robertson M.J., Levine H., Manley T.J., Schow P.W., Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol. 22:1992;1-6.
6. Borrego F., Lopez-Beltran A., Pena J., Solana R. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C. Cell Immunol. 158:1994;208-217.
7. Borrego F., Pena J., Solana R. Regulation of CD69 expression on human natural killer cells Differential involvement of protein kinase C and protein tyrosine kinases . Eur J Immunol. 23:1993;1039-1043.
8. Caligiuri M.A., Zmuidzinas A., Manley T.J., Smith K., Ritz J. Functional consequences of interleukin-2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinitty receptors. J Exp Med. 171:1990;1509-1515.
9. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Taniguchi M. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1997;1623-1626.
10. Facchini A., Mariani E., Mariani A.R., Papa S., Vitale M., Manzoli F.A. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol. 68:1987;340-347.
11. Huppert F.A., Solomou W., O'Connor S., Morgan K., Sussams P., Brayne C. Aging and lymphocyte subpopulations Whole-blood analysis of immune markers in a large population sample of healthy elderly individuals . Exp Gerontol. 33:1998;593-600.
12. Kawamura T., Takeda K., Mendiratta S.K., Kawamura H., Van Kaer L., Yagita H., Abo T., Okumura K. Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. J Immunol. 160:1998;16-19.
13. Koyasu S. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells. J Exp Med. 179:1994;1957-1972.
14. Krishnaraj R. Immunosenescence of human NK cells Effects on tumor target recognition, lethal hit and interferon sensitivity . Immunol Lett. 34:1992;79-84.
15. Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev. 96:1997;89-101.
16. Krishnaraj R., Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2.IL2-induced interferon gamma secretion. Immunol Lett. 50:1996;59-63.
17. Krishnaraj R., Svanborg A. Preferential accumulation of mature NK cells during human immunosenescence. J Cell Biochem. 50:1992;386-391.
18. Kutza J., Murasko D.M. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol. 155:1994;195-204.
19. Kutza J., Murasko D.M. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev. 90:1996;209-222.
20. Lanier L.L. NK cell receptors. Annu Rev Immunol. 16:1998;359-393.
21. Lanier L.L., Hemperly J.J. CD56 and CD57 cluster workshop report. Schlossman S.F., Boumsell L., Gilks W., Harlan J.M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T.F., Todd R.F. Leucocyte Typing V. 1995;1398-1400 Oxford University Press, Oxford.
22. Ligthart G.J., Corberand J.X., Geertzen H.G., Meinders A.E., Knook D.L., Hijmans W. Necessity of the assessment of health status in human immunogerontological studies Evaluation of the SENIEUR protocol . Mech Ageing Dev. 55:1990;89-105.
23. Lopez-Botet M. CD94 cluster report Overview of the characterization of the Kp43 NK-cell-associated surface antigen . Schlossman S.F., Boumsell L., Gilks W., Harlan J.M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T.F., Todd R.F. Leucocyte Typing V. 1995;1437-1439 Oxford University Press, Oxford.
24. Lopez-Botet M., Carretero M., Bellon T., Perez-Villar J.J., Llano M., Navarro F. The CD94/NKG2 C-type lectin receptor complex. Curr Top Microbiol Immunol. 230:1998;41-52.
25. Lopez-Botet M., Moretta L., Strominger J. NK-cell receptors and recognition of MHC class I molecules. Immunol Today. 17:1996;212-214.
26. Lopez-Botet M., Perez-Villar J.J., Carretero M., Rodriguez A., Melero I., Bellon T., Llano M., Navarro F. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev. 155:1997;165-174.
27. Mariani E., Mariani A.R., Meneghetti A., Tarozzi A., Cocco L., Facchini A. Age-dependent decreases of NK cell phosphoinisitide turnover during spontaneous but not Fc mediated cytotolytic activity. Int Immunol. 10:1998;981-989.
28. Mariani E., Monaco M.C., Cattini L., Sinoppi M., Facchini A. Distribution and lytic activity of NK cell subsets in the elderly. Mech Ageing Dev. 76:1994;177-187.
29. Mariani E., Roda P., Mariani A.R., Vitale M., Degrassi A., Papa S., Facchini A. Age-associated changes in CD8+ and CD16+ cell reactivity Clonal analysis . Clin Exp Immunol. 81:1990;479-484.
30. Mariani E., Sgobbi S., Meneghetti A., Tadolini M., Tarozzi A., Sinoppi M., Cattini L., Facchini A. Perforins in human cytolytic cells The effect of age . Mech Ageing Dev. 92:1996;195-209.
31. McNerlan S.E., Rea I.M., Alexander H.D., Morris T.C. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol. 18:1998;31-38.
32. Miyaji C., Watanabe H., Minagawa M., Toma H., Kawamura T., Nohara Y., Nozaki H., Sato Y., Abo T. Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol. 17:1997;420-429.
33. Moretta L., Ciccone E., Poggi A., Mingari M.C., Moretta A. Ontogeny, MHC class I specificity and receptors of human natural killer cells. Solana R., Pena J. MHC Antigens and NK Cells. 1994;92-104 R. G. Landes Co, Austin, TX.
34. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K., Nomura T. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. 84:1997;269-275.
35. Okada T., Iiai T., Kawachi Y., Moroda T., Takii Y., Hatakeyama K., Abo T. Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer. Clin Exp Immunol. 102:1995;159-166.
36. Onsrud M. Age dependent changes in some human lymphocyte sub-populations. Changes in natural killer cell activity. Acta Pathol Microbiol Scand [C]. 89:1981;55-62.
37. Pawelec G., Adibzadeh M., Solana R., Beckman I. The T cell in the ageing individual. Mech Ageing Dev. 93:1997;35-45.
38. Pawelec G., Mariani E., Offringa R., Melief C.J.M., Solana R. Generation and characterization of killer cells. Methods Microbiol. 25:1998;605-619.
39. Pawelec G., Remarque E., Barnett Y., Solana R. T cells and aging. Front Biosci. 3:1998;d59-d99.
40. Pawelec G., Solana R. Immunosenescence. Immunol Today. 18:1997;514-516.
41. Pena J., Solana R. Effect of target cell histocompatibility antigens in NK-cell mediated recognition and lysis. Solana R., Pena J. MHC Antigens and NK Cells. 1994;16-34 R. G. Landes Co, Austin, TX.
42. Potestio M., Caruso C., Gervasi F., Scialabba G., D'Anna C., Di Lorenzo G., Balistreri C., Candore G., Romano G.C. Apoptosis and ageing. Mech Ageing Dev. 102:1998;201-237.
43. Poynter M.E., Mu H.H., Chen X.P., Daynes R.A. Activation of NK1.1+ T cells in vitro and their possible role in age-associated changes in inducible IL-4 production. Cell Immunol. 179:1997;22-29.
44. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 102:1998;199-210.
45. Robertson M.J., Solana R. Reactivity and functional properties of NK-cell panel mAb. Schlossman S.F., Boumsell L., Gilks W., Harlan J.M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T.F., Todd R.F. Leucocyte Typing V. 1995;1373-1374 Oxford University Press, Oxford.
46. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
47. Shirai K., Watanabe H., Weerasinghe A., Sakai T., Sekikawa H., Abo T. A monoclonal antibody, DL10, which recognizes a sugar moiety of MHC class I antigens expressed on NK cells, NK+ T cells, and granulocytes in humans. J Clin Immunol. 17:1997;510-523.
48. Solana R., Pena J. Natural Killer cells receptors Activation and inhibition of NK cell mediated cytotoxicity . Solana R., Pena J. MHC Antigens and NK Cells. 1994;16-34 R. G. Landes Co, Austin TX.
49. Sugiyama E., Ito M., Suzuki H., Yamashita N., Maruyama M., Yano S. Natural killer cell activity associated with aging and sex in humans. Jpn J Med. 22:1983;195-199.
50. Takii Y., Hashimoto S., Iiai T., Watanabe H., Hatakeyama K., Abo T. Increase in the proportion of granulated CD56+ T cells in patients with malignancy. Clin Exp Immunol. 97:1994;522-527.
51. Tamada K., Harada M., Abe K., Li T., Tada H., Onoe Y., Nomoto K. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes. J Immunol. 158:1997;4846-4854.
52. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
53. Trinchieri G. Definition and biology of natural killer cells. Solana R., Pena J. MHC Antigens and NK Cells. 1994;1-15 R. G. Landes Co, Austin, TX.
54. Tsukahara A., Seki S., Iiai T., Moroda T., Watanabe H., Suzuki S., Tada T., Hiraide H., Hatakeyama K., Abo T. Mouse liver T cells Their change with aging and in comparison with peripheral T cells . Hepatology. 26:1997;301-309.
55. Vitale M., Zamai L., Neri L.M., Galanzi A., Facchini A., Rana R., Cataldi A., Papa S. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol. 145:1992;1-10.